Tumor-specific transplantation resistance in mice after treatment of initial tumors with Streptococcus thermophilus.
Antitumor activity observed by treatment with Streptococcus thermophilus was further investigated. The mice cured from fibrosarcoma by treatment with heat-killed preparation of S. thermophilus, when challenged with fibrosarcoma failed to take up the tumor. However, these cured mice when challenged with sarcoma-180 or Ehrlich ascites carcinoma, did not show significant changes in tumor take and/or survival compared to their respective controls. Similarly, mice cured from sarcoma-180 were challenged with fibrosarcoma, sarcoma-180 or Ehrlich ascites carcinoma. Though there was no change in the mean survival time (MST) of the dying mice regarding sarcoma-180 or Ehrlich ascites carcinoma, there was 50 and 30% increase in the number of mice that showed total regression respectively over controls. However, there was no difference in the growth rate of fibrosarcoma. Similar observations were made with mice cured from Ehrlich ascites carcinoma, challenged with these tumors. These findings thus suggest that the antitumor response was tumor-specific and that tumor-associated antigens may have a role in imparting this specificity. Bacterial treatment non-specifically augmented this primary response.
Kaklij
G S
GS
Radiation Biology and Biochemistry Division, Bhabha Atomic Research Centre, Bombay, India.
Kelkar
S M
SM
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000276:immunology / Q000517:prevention & control; D005354:Fibrosarcoma / Q000276:immunology / Q000517:prevention & control*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D012510:Sarcoma 180 / Q000276:immunology / Q000517:prevention & control; D013291:Streptococcus / Q000276:immunology*; D015164:Vaccines, Inactivated / Q000627:therapeutic use*
D015164:Vaccines, Inactivated